MedTrace Logo

Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia

NCT01644981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2016-05-10

No results posted yet for this study

Summary

Serial quantitative measurements of plasma pro-endothelin-1 concentrations in very preterm infants. Comparing pro-endothelin-1 with established clinical indices of bronchopulmonary dysplasia (BPD). Hypothesis: Pulmonary-vascular remodeling in infants developing BPD is directly related to circulating pro-endothelin-1, which therefore serves as surrogate marker of BPD.

Conditions

  • Bronchopulmonary Dysplasia

Interventions

OTHER

blood sampling

blood sampling

Sponsors & Collaborators

  • University Children's Hospital Basel

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Sven Wellmann, MD · University Hospital Zurich, Division of Neonatology

Eligibility

Min Age
2 Weeks
Max Age
4 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01644981 on ClinicalTrials.gov